Podcast: KHN’s ‘What The Health?’ Health On The Hill

In this episode of KHN’s “What the Health?” Julie Rovner of Kaiser Health News, Rebecca Adams of CQ Roll Call, Margot Sanger-Katz of The New York Times and Joanne Kenen of Politico talk about a spate of health-related legislative action on Capitol Hill, including Senate passage of a bill to address the opioid epidemic. Plus, for extra credit, the panelists recommend their favorite health policy stories of the week.

Half As Many People Are Trying Heroin, But Marijuana Use Grows

An annual government survey of drug use and health shows a dramatic drop in the number of people who tried heroin but an uptick in pot use.

Unwitting Patients, Copycat Comments Play Hidden Role In Federal Rule-Making

As HHS decided to cut $1.6 billion in drug payments to hospitals, it weighed thousands of comments generated by a pharmaceutical-funded advocacy group.

Podcast: KHN’s ‘What The Health?’ Opioids, EpiPens And Health Funding

In this episode of KHN’s “What the Health?” Julie Rovner of Kaiser Health News, Alice Ollstein of Talking Points Memo, Margot Sanger-Katz of The New York Times and Joanne Kenen of Politico discuss Senate action on health funding and opioid legislation, the state of the individual insurance market and consternation over expiration dates on EpiPens, the self-injected allergy remedy. Also, could an otter with asthma signal a potential public health crisis?

Podcast: KHN’s ‘What The Health?’ See You In Court!

In this episode of KHN’s “What the Health?” Julie Rovner of Kaiser Health News, Alice Ollstein of Talking Points Memo, Margot Sanger-Katz of The New York Times and Kimberly Leonard of the Washington Examiner talk about a spate of lawsuits involving the Affordable Care Act, as well as the latest in state and federal efforts regarding the Medicaid program for the poor.

Trump Administration Sinks Teeth Into Paring Down Drug Prices, On 5 Key Points

Instead of waiting for congressional action, federal regulators are looking at a series of actions to spur competition and drive down the cost of medicines.

Trump Administration Sinks Teeth Into Paring Down Drug Prices, On 5 Key Points

Instead of waiting for congressional action, federal regulators are looking at a series of actions to spur competition and drive down the cost of medicines.

Pharmacy-Made Pain Creams Flagged On Fears Of Medicare Fraud And Risk

Inspector general identifies possible problems in nearly 23 percent of pharmacies that bill Medicare for blended creams, gels and lotions.

Pharmacy-Made Pain Creams Flagged On Fears Of Medicare Fraud And Risk

Inspector general identifies possible problems in nearly 23 percent of pharmacies that bill Medicare for blended creams, gels and lotions.

To Tame Prescription Prices, HHS Dips A Toe Into Drug Importation Stream

The Trump administration signals it is willing to consider such a move if it is carefully tailored to focus solely on specific situations where a high-priced drug is made by one company.

Older posts «

Explore the Archive